Nammi Therapeutics
Latest round
- Series B
Last raised
- Mar 2023
Total raised
- $28M
Investors
- 1
About Nammi Therapeutics
Nammi Therapeutics focuses on immunotherapy solutions for cancer treatment. The company is headquartered in Los Angeles, US, and was founded by David Stover, who also serves as CEO.Nammi Therapeutics specializes in immunotherapy products designed to activate the immune system at tumor sites, minimizing systemic side effects. Their main offerings include Masked ImmunoCytokines (MICs), which combine tumor-targeting antibodies with cytokines, and Nammisomes, lipid nanoparticles delivering immune modulators.Nammi Therapeutics generates revenue through partnerships and collaborations with pharmaceutical companies and healthcare providers in the immunotherapy sector. Their revenue model includes direct sales of proprietary products, with flagship items like QXL138AM and SLNP-IC1 targeting specialized oncology markets to improve patient outcomes in cancer care. The company is focusing on launching new products designed for targeted cancer therapies and aims to expand its market presence into additional regions in North America and Asia by 2025.
Who invested in Nammi Therapeutics
1 investor across 1 round
See all investors in Nammi Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Mar 3, 2023
Amount
$28M
Investors
Questions about Nammi Therapeutics
Who invested in Nammi Therapeutics?
Nammi Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nammi Therapeutics raised?
Nammi Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Nammi Therapeutics last raise money?
Nammi Therapeutics's most recent round on record is a Series B, in Mar 2023.
What does Nammi Therapeutics do?
Nammi Therapeutics focuses on immunotherapy solutions for cancer treatment.
Where is Nammi Therapeutics headquartered?
Nammi Therapeutics is headquartered in Los Angeles, US.
Which VCs invest in companies like Nammi Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Nammi Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Nammi Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.